RedHill Biopharma (RDHL) Return on Sales (2012 - 2023)
RedHill Biopharma (RDHL) posted quarterly Return on Sales of 0.33% for Q2 2023, up 32.0% year-over-year from 0.25% in Q2 2022, and up 1590.99% quarter-over-quarter from 0.02% in Q1 2023.
RedHill Biopharma (RDHL) Return on Sales (2012 - 2023) Analysis & Trends
RedHill Biopharma (RDHL) has reported Return on Sales for 12 consecutive years, with 0.33% the latest figure, recorded in Q2 2023.
- In Q2 2023, Return on Sales rose 32.0% year-over-year to 0.33%; the TTM figure through Jun 2023 stood at 0.01% (changed 0.0% YoY), while the FY2025 annual figure was 0.27%, up 28.0% from the prior year.
- Return on Sales climbed to 0.33% in Q2 2023 per RDHL's latest filing, from 0.02% in the prior quarter.
- Across five years, Return on Sales topped out at 0.33% in Q2 2023 and bottomed at 0.06% in Q4 2021.
- Historically, Return on Sales has averaged 0.04% across 5 years, with a median of 0.01% in 2021.
- Annual changes were most pronounced in 2021 — Return on Sales decreased 15 bps — and 2023, when it surged 32 bps.
- RedHill Biopharma's Return on Sales stood at 0.07% in 2019, then tumbled by 93 bps to 0.0% in 2020, then slumped by 1412 bps to 0.06% in 2021, then gained by 16 bps to 0.05% in 2022, then surged by 704 bps to 0.33% in 2023.
- Business Quant data shows RDHL's Return on Sales at 0.33% in Q2 2023, 0.02% in Q1 2023, and 0.05% in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 0.00% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 0.00% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.00% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 0.33% |
| Mar 31, 2023 | -0.02% |
| Dec 31, 2022 | -0.05% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.01% |
| Dec 31, 2021 | -0.06% |
| Sep 30, 2021 | 0.01% |
| Jun 30, 2021 | 0.01% |
| Mar 31, 2021 | 0.01% |
| Dec 31, 2020 | 0.00% |
| Sep 30, 2020 | 0.00% |
| Jun 30, 2020 | 0.00% |
| Mar 31, 2020 | 0.16% |
| Dec 31, 2019 | 0.07% |
| Sep 30, 2019 | 0.07% |
| Jun 30, 2019 | 0.09% |
| Mar 31, 2019 | 0.05% |
| Dec 31, 2018 | 0.09% |
| Sep 30, 2018 | 0.04% |